Rogletimide

Rogletimide

SCHEMBL28110686

CCC1(c2ccncc2)CCC(=O)NC1=O.CN

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 19/20 0.94
CYP3A4 P08684 2/20 0.69
CYP17A1 P05093 1/20 0.69
CYP11A1 P05108 1/20 0.69
TBXAS1 P24557 1/20 0.69
PMP22 Q01453 1/20 0.69
PDE4D Q08499 1/20 0.69
PDE3A Q14432 1/20 0.69
NFKB1 P19838 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rogletimide SCHEMBL9372682 0.97 CYP19A1 (1.00) CYP19A1CYP3A4CYP17A1CYP11A1TBXAS1
Rogletimide SCHEMBL4281 0.97 CYP19A1 (1.00) CYP19A1CYP3A4CYP17A1CYP11A1TBXAS1
SCHEMBL3296751 0.83 CYP19A1 (1.00) CYP19A1
Aminoglutethimide SCHEMBL4306 0.82 CYP19A1 (1.00) CYP19A1CYP3A4CYP17A1CYP11A1TBXAS1
Aminoglutethimide SCHEMBL1230613 0.82 CYP19A1 (1.00) CYP19A1CYP3A4CYP17A1CYP11A1TBXAS1
Aminoglutethimide SCHEMBL116988 0.82 CYP19A1 (1.00) CYP19A1CYP3A4CYP17A1CYP11A1TBXAS1
Aminoglutethimide SCHEMBL7728932 0.82 CYP19A1 (1.00) CYP19A1CYP3A4CYP17A1CYP11A1TBXAS1
Glutethimide SCHEMBL113709 0.81 CYP19A1 (0.72) CYP19A1CYP3A4CYP17A1CYP11A1TBXAS1
Glutethimide SCHEMBL21119240 0.81 CYP19A1 (0.72) CYP19A1CYP3A4CYP17A1CYP11A1TBXAS1
Glutethimide SCHEMBL113708 0.81 CYP19A1 (0.72) CYP19A1CYP3A4CYP17A1CYP11A1TBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106167483-B It can be used for compound, composition and the method for cholesterol mobilization 塞伦尼斯医疗控股有限公司 2019-02-15 CN disclosed
CN-107011359-A Compound, composition and the method mobilized available for cholesterol 塞伦尼斯医疗控股有限公司 2017-08-04 CN disclosed
CN-103442714-B Compounds, compositions and methods useful for cholesterol mobilization 塞伦尼斯医疗控股有限公司 2017-04-19 CN disclosed
CN-106167483-A Can be used for compound, compositions and method that cholesterol is mobilized 塞伦尼斯医疗控股有限公司 2016-11-30 CN disclosed